Ricardo Vitor Cohen

Learn More
OBJECTIVE Roux-en-Y gastric bypass (RYGB) ameliorates type 2 diabetes in severely obese patients through mechanisms beyond just weight loss, and it may benefit less obese diabetic patients. We determined the long-term impact of RYGB on patients with diabetes and only class I obesity. RESEARCH DESIGN AND METHODS Sixty-six consecutively selected diabetic(More)
W e thank Dr. Kral for his thoughtful comments on our article regarding the use of Roux-en-Y gastric bypass surgery (RYGB) to treat type 2 diabetes (T2DM), and we would like to respond and add to his comments (1). Although the 1991 National Institutes of Health (NIH) guidelines were thoughtfully constructed and have been highly valuable, we agree that they(More)
Posição da SBCBM-nomenclatura e definicões para os resultados em cirurgia bariátrica e metabólica O besity was initially regarded as a psychosocial disorder, but, after years of study, has come to be understood as a chronic disease for which there is no cure, like hypertension and diabetes 6,7. Surgical intervention is safe and effective in the long term(More)
INTRODUCTION Obesity and overweight are becoming progressively more prevalent worldwide and are independently associated with a significant increase in the risk of cardiovascular diseases. Systemic arterial hypertension is frequently found in association with obesity and contributes significantly to increased cardiovascular risk. We hypothesise that(More)
F rom the first cases performed in 1974 and the growing interest aroused in surgeons in 1996 was founded the Brazilian Society for Bariatric Surgery, being in the same year associated with IFSO (International Federation for the Surgery of Obesity and Metabolic Disorders) which enabled the performance the 7 th World Congress and IFSO First World Bariatric(More)
Introduction Even considering the advance of the medical treatment in the last 20 years with new and more effective drugs, the outcomes are still disappointing as the control of obesity and type 2 Diabetes Mellitus (T2DM) with a large number of patients under the medical treatment still not reaching the desired outcomes. Objective: To present a Metabolic(More)
OBJECTIVE To determine whether upper gastrointestinal tract (UGI) bypass itself has beneficial effects on the factors involved in regulating glucose homeostasis in patients with type 2 diabetes (T2D). METHODS A 12-month randomized controlled trial was conducted in 17 overweight/obese subjects with T2D, who received standard medical care (SC, n = 7, BMI =(More)
INTRODUCTION There are several randomised controlled trials (RCTs) that have already shown that metabolic/bariatric surgery achieves short-term and long-term glycaemic control while there are no level 1A of evidence data regarding the effects of surgery on the microvascular complications of type 2 diabetes mellitus (T2DM). PURPOSE The aim of this trial is(More)
  • 1